Tealdo Tiziano, Menini Maria, Bevilacqua Marco, Pera Francesco, Capalbo Vanessa, Pera Paolo
Department of Fixed and Implant Prosthodontics, University of Genoa, Genoa, Italy.
Clin Oral Implants Res. 2015 Jan;26(1):83-89. doi: 10.1111/clr.12287. Epub 2013 Nov 8.
Short-term results indicated that the Brånemark Novum protocol (Nobel Biocare AB, Goteborg, Sweden) allowed successful rehabilitation of mandibular edentulism with immediately loaded implants. Yet, long-term studies are lacking. The aim of the present retrospective study was to report the 11-year outcomes for patients treated according to this protocol.
Four patients treated according to the Brånemark Novum protocol (Nobel Biocare AB) were followed-up to evaluate implant and prosthesis cumulative survival rate (CSR), implant stability (RFA), marginal bone loss by periapical radiographs, probing depth (PD), and possible complications. Clinical and radiographic parameters were evaluated immediately after completion of the treatment and 1, 5, and 11 years after loading.
The 11-year implant and prosthesis CSRs were 100%. Implant stability (RFA values) remained stable over the 11-year follow-up. Small bone resorption was found next to distal implants (median 1 mm) after 11 years, while central implants showed greater bone resorption (median 4.5 mm). The PD (mean 3.75 mm at 11 years) grew together with marginal bone loss. One implant complication was detected on a central implant (crater-form bone destruction), and 10 prosthetic complications (fractures of resin or teeth), 80% of which registered on the same parafunctional patient.
The 11-year results demonstrated that the Brånemark Novum protocol (Nobel Biocare AB) is a predictable technique with favorable long-term outcomes. This was a rigid protocol, which could be applied only in patients with specific anatomical characteristics of the lower jaw, but it had the merit of indicating the key factors for full-arch immediate loading rehabilitations.
短期结果表明,Brånemark Novum方案(诺贝尔生物科技公司,瑞典哥德堡)可通过即刻负重种植体成功修复下颌无牙颌。然而,目前仍缺乏长期研究。本回顾性研究的目的是报告按照该方案治疗的患者11年的治疗结果。
对4例按照Brånemark Novum方案(诺贝尔生物科技公司)治疗的患者进行随访,以评估种植体和修复体的累积留存率(CSR)、种植体稳定性(共振频率分析,RFA)、根尖片显示的边缘骨吸收、探诊深度(PD)以及可能出现的并发症。在治疗完成后即刻以及负重后1年、5年和11年对临床和影像学参数进行评估。
11年时种植体和修复体的CSR均为100%。在11年的随访期间,种植体稳定性(RFA值)保持稳定。11年后,发现远中种植体旁有少量骨吸收(中位值为1 mm),而中央种植体的骨吸收更为明显(中位值为4.5 mm)。PD(11年时平均为3.75 mm)随边缘骨吸收增加。在一枚中央种植体上检测到1例种植体并发症(火山口状骨破坏),以及10例修复体并发症(树脂或牙齿折断),其中80%发生在同一例有异常功能的患者身上。
11年的结果表明,Brånemark Novum方案(诺贝尔生物科技公司)是一种可预测的技术,长期效果良好。这是一个严格的方案,仅适用于具有特定下颌解剖特征的患者,但它有助于明确全牙弓即刻负重修复的关键因素。